BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12940467)

  • 21. Substance abuse studies and prevention efforts among Arabs in the 1990s in Israel, Jordan and the Palestinian Authority--a literature review.
    Weiss S; Sawa GH; Abdeen Z; Yanai J
    Addiction; 1999 Feb; 94(2):177-98. PubMed ID: 10396784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Correspondence Between Causal and Traditional Mediation Analysis: the Link Is the Mediator by Treatment Interaction.
    MacKinnon DP; Valente MJ; Gonzalez O
    Prev Sci; 2020 Feb; 21(2):147-157. PubMed ID: 31833021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How can statistical approaches enhance transdisciplinary study of drug misuse prevention?
    Chou CP; Spruijt-Metz D; Azen SP
    Subst Use Misuse; 2004; 39(10-12):1867-906. PubMed ID: 15587953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seven ways to increase power without increasing N.
    Hansen WB; Collins LM
    NIDA Res Monogr; 1994; 142():184-95. PubMed ID: 9243537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis with missing data in drug prevention research.
    Graham JW; Hofer SM; Piccinin AM
    NIDA Res Monogr; 1994; 142():13-63. PubMed ID: 9243532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some design, measurement, and analysis pitfalls in drug abuse prevention research and how to avoid them: let your model be your guide.
    Collins LM
    NIDA Res Monogr; 1994; 139():95-114. PubMed ID: 8742553
    [No Abstract]   [Full Text] [Related]  

  • 27. Whole-school interventions promoting student commitment to school to prevent substance use and violence, and improve educational attainment: a systematic review.
    Ponsford R; Melendez-Torres GJ; Miners A; Falconer J; Bonell C
    Public Health Res (Southampt); 2024 Feb; 12(2):1-290. PubMed ID: 38356404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for analysis of skewed data distributions in psychiatric clinical studies: working with many zero values.
    Delucchi KL; Bostrom A
    Am J Psychiatry; 2004 Jul; 161(7):1159-68. PubMed ID: 15229044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated Measures Designs and Analysis of Longitudinal Data: If at First You Do Not Succeed-Try, Try Again.
    Schober P; Vetter TR
    Anesth Analg; 2018 Aug; 127(2):569-575. PubMed ID: 29905618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating intervention effects in longitudinal studies.
    Dwyer JH; MacKinnon DP; Pentz MA; Flay BR; Hansen WB; Wang EY; Johnson CA
    Am J Epidemiol; 1989 Oct; 130(4):781-95. PubMed ID: 2773920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the Mplus computer program to estimate models for continuous and categorical data from twins.
    Prescott CA
    Behav Genet; 2004 Jan; 34(1):17-40. PubMed ID: 14739694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of adolescent drug prevention programs: results of the 1993 meta-analysis.
    Tobler NS
    NIDA Res Monogr; 1997; 170():5-68. PubMed ID: 9154251
    [No Abstract]   [Full Text] [Related]  

  • 33. Differences in perceived implementation of a standard versus peer-led interactive substance abuse prevention program.
    Valente TW; Okamoto J; Pumpuang P; Okamoto P; Sussman S
    Am J Health Behav; 2007; 31(3):297-311. PubMed ID: 17402869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome measurement issues in drug abuse prevention studies.
    Dwyer JH; MacKinnon DP
    NIDA Res Monogr; 1991; 107():183-94. PubMed ID: 1922305
    [No Abstract]   [Full Text] [Related]  

  • 35. [A review of statistical analysis methods in measurement data].
    Cai Y
    Shanghai Kou Qiang Yi Xue; 2004 Jun; 13(3):198-200. PubMed ID: 15269858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation analysis in psychosomatic medicine research.
    Lockhart G; MacKinnon DP; Ohlrich V
    Psychosom Med; 2011 Jan; 73(1):29-43. PubMed ID: 21148809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An illustration of item homogeneity scaling and multilevel analysis techniques in the evaluation of drug prevention programs.
    Kreft IG
    Eval Rev; 1998 Feb; 22(1):46-77. PubMed ID: 10183301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic wait-listed designs for randomized trials: new designs for prevention of youth suicide.
    Brown CH; Wyman PA; Guo J; Peña J
    Clin Trials; 2006; 3(3):259-71. PubMed ID: 16895043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consumer Health Information Technology in the Prevention of Substance Abuse: Scoping Review.
    Pradhan AM; Park L; Shaya FT; Finkelstein J
    J Med Internet Res; 2019 Jan; 21(1):e11297. PubMed ID: 30698526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small sample randomized clinical trial methodology using N-of-1 designs and mixed model analysis.
    Ridenour TA; Hall DL; Bost JE
    Am J Drug Alcohol Abuse; 2009; 35(4):260-6. PubMed ID: 20180679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.